banner add

UnitedHealth’s Revenues Rise, in First Earnings Report Since CEO’s Killing

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it had made less than analysts expected.

from NYT > Health https://ift.tt/f2jTkLn
via IFTTT

No comments

The Ruthless Efficiency of Ultrapotent Street Drugs

Five decades after the “war on drugs” sought to make substance abuse unaffordable, illicit drugs are cheaper and more powerful than ever. A ...

Theme images by PLAINVIEW. Powered by Blogger.